Rekah Pharmaceutical Industry Ltd. (TLV: REKA)

TLV: REKA Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3.68	19.31	20.21	18.6	36.89	25.57
Short-Term Investments	0.04	-	-	-	-	-
Trading Asset Securities	-	0.04	0.08	0.04	0.04	0.04
Cash & Short-Term Investments	3.72	19.35	20.29	18.64	36.93	25.61
Cash Growth	-73.52%	-4.63%	8.83%	-49.52%	44.22%	-19.31%
Accounts Receivable	129.38	117.68	120.71	107.37	87.63	77.49
Other Receivables	10.41	8.67	6.83	2.25	1.98	2.89
Receivables	139.79	126.35	127.54	109.62	89.61	80.38
Inventory	86.82	96.6	92.2	89.61	97.85	69.19
Prepaid Expenses	-	1.94	1.83	1.42	0.71	0.74
Other Current Assets	-	7.09	1.28	2.37	2.25	1.77
Total Current Assets	230.32	251.33	243.14	221.66	227.35	177.68
Property, Plant & Equipment	144.77	154.62	163.21	177	181.82	181.02
Long-Term Investments	1.23	1.17	-	-	1.84	2.39
Goodwill	35.14	35.14	15.18	-	-	-
Other Intangible Assets	27.07	31.66	20.67	32.97	4.18	2.44
Long-Term Deferred Tax Assets	15.82	10.79	6.22	5.46	4.5	3.58
Other Long-Term Assets	-	0.01	0.01	0.01	0.01	0.01
Total Assets	454.36	484.72	448.42	437.09	419.69	367.11
Accounts Payable	95.83	78.89	81.21	57.44	59.89	47.03
Accrued Expenses	-	23.95	17.05	13.61	12.96	10.24
Short-Term Debt	34.13	3.12	-	0.01	5	0
Current Portion of Long-Term Debt	6.47	26.94	30.9	18.96	22.06	20.61
Current Portion of Leases	7.41	6.9	5.59	5.03	4.82	4.6
Current Income Taxes Payable	0.39	1.56	0.76	0.26	0.96	0.6
Current Unearned Revenue	-	0.13	0.1	0.25	0.88	0.47
Other Current Liabilities	16.59	2.31	3.44	3.04	1.7	1.13
Total Current Liabilities	160.81	143.79	139.03	98.61	108.26	84.68
Long-Term Debt	64.17	110.09	91.66	101.23	90.86	72.9
Long-Term Leases	35.24	38.76	37.55	40.6	43.6	46.15
Long-Term Deferred Tax Liabilities	5.43	6.03	2.75	3.16	-	-
Other Long-Term Liabilities	13.87	20.74	6.49	11.21	2	-
Total Liabilities	289.98	329.14	286.34	264.03	254.1	211.89
Common Stock	13.64	13.64	13.64	13.64	13.64	13.64
Additional Paid-In Capital	126.61	126.61	126.61	126.61	126.61	126.61
Retained Earnings	23.56	14.67	21.35	32.73	25.69	15.41
Treasury Stock	-0.51	-0.51	-0.51	-0.51	-0.51	-0.51
Comprehensive Income & Other	1.02	1.12	0.93	0.54	0.09	-
Total Common Equity	164.33	155.54	162.03	173.01	165.53	155.16
Minority Interest	0.05	0.05	0.05	0.05	0.06	0.06
Shareholders' Equity	164.37	155.59	162.08	173.07	165.59	155.22
Total Liabilities & Equity	454.36	484.72	448.42	437.09	419.69	367.11
Total Debt	147.41	185.8	165.7	165.82	166.34	144.27
Net Cash (Debt)	-143.69	-166.45	-145.41	-147.18	-129.41	-118.66
Net Cash Per Share	-12.81	-14.58	-12.74	-12.89	-11.34	-10.40
Filing Date Shares Outstanding	11.41	11.41	11.41	11.41	11.41	11.41
Total Common Shares Outstanding	11.41	11.41	11.41	11.41	11.41	11.41
Working Capital	69.51	107.54	104.11	123.05	119.09	93
Book Value Per Share	14.40	13.63	14.19	15.16	14.50	13.59
Tangible Book Value	102.11	88.73	126.18	140.05	161.35	152.72
Tangible Book Value Per Share	8.95	7.77	11.05	12.27	14.14	13.38
Land	-	1.89	2.07	2.07	2.07	2.07
Buildings	-	117.94	124.71	122.66	119.21	116.97
Machinery	-	121.03	112.99	109.84	106.6	99.01
Leasehold Improvements	-	61.15	58.28	57.23	54.74	47.62

Source: S&P Capital IQ. Standard template. Financial Sources.